Anti-prothrombin antibodies in type 1 Diabetes Mellitus

BAKAR ATEŞ F., ÜNLÜTÜRK U., Baskal N., Nebioglu S.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.38, sa.4, ss.432-437, 2013 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5505/tjb.2013.69188
  • Dergi Adı: TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.432-437
  • Anahtar Kelimeler: Type 1 diabetes, thrombosis, anti-prothrombin, anti-beta 2GP1, TISSUE-PLASMINOGEN ACTIVATOR, ANTIPROTHROMBIN ANTIBODIES, ANTIPHOSPHOLIPID SYNDROME, ANTIPHOSPHATIDYLSERINE/PROTHROMBIN ANTIBODIES, BETA(2)-GLYCOPROTEIN I, AUTOANTIBODIES, THROMBOSIS, RISK, BETA-2-GLYCOPROTEIN-I, PHOSPHATIDYLSERINE
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: Type 1 diabetes mellitus (T1DM) is an autoimmune disease, and autoimmunity related prothrombotic factors might contribute to the hypercoagulable state seen in T1DM. The aim of this study is to investigate the presence of anti-prothrombin (aPT) antibodies as a prothrombotic risk factor in patients with T1DM.